The Company "announces that its auditor, KPMG has resigned effective as of December 8, 2022, and that the Audit Committee of the Board of Directors of the Company approved the engagement of Marcum LLP as its auditor, subject to Marcum’s completion of their client acceptance procedures. Marcum will stand for appointment at the Company’s Annual General Meeting, currently scheduled for Thursday, December 15, 2022. KPMG has confirmed that there are no reportable events (as such term is defined in National Instrument 51-102 – Continuous Disclosure Obligations."
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on INM:
- InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
- InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
- InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
- InMed Provides Update on Management Changes
- InMed Pharmaceuticals reports Q1 EPS ($4.06) vs. ($6.17) a year ago